.jpg)
Rapid Micro Biosystems
IPOAutomated Quality Control Microbiology
Public · Lowell, United States · $217.2M raised
- Headquarters
- Lowell, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- rapidmicrobio.com
- Total Funding
- $217.2M
- Last Round
- $25.0M Series CMar 2021
- Rounds
- 5
- Type
- Public
About
Develops automated microbiology quality control systems for biomanufacturing, enabling fast and accurate microbial contamination detection.
Summary
Rapid Micro Biosystems is a Biotech company based in Lowell, United States. It has raised $217.2M in total across 5 rounds, most recently a $25.0M Series C round in Mar 2021. Investors include Bain Capital Life Sciences, MLS Capital Fund II and D1 Capital Partners.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2021
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...